Dire Diplomacy in Global “Race for Vaccine”: Wired

The US Naval Medical Research Center once had more than 12 labs around the world, developing foreign partnerships to identify emerging disease. A research team identified the avian flu in Indonesia in 2005, though the partnerships had been deteriorating in 1998 over concerns about vaccine sales, suspended aid and spying worries. The 9/11 attacks and the 2008 financial crisis then reduced budgets for health research. “As we confront a new pandemic that has been exacerbated by the grandstanding of our politicians, it is the open-data scientists and mission-driven doctors who may have the largest role in defusing the inevitable conflicts that lay ahead,” writes Brendan Borrell for Wired. “They know that the best way to erode global inequities is by setting aside concerns about intellectual property, sharing their data as widely as possible, and leveraging research collaborations....” The first nation to produce an effective vaccine will attract global influence. That could be China, which also expands its global health outreach in Africa, Asia and South America. The US, which elied on other nations for genetic sequencing of the virus and biological data for developing tests did not sign on to a World Health Organization initiative to ensure equitable distribution of vaccines and medicines. Borrell concludes, “Stopping this pandemic and preventing the next one depends on American scientists’ ability to forge durable partnerships with foreign scientists.” – YaleGlobal

Dire Diplomacy in Global “Race for Vaccine”: Wired

Stopping the Covid-19 pandemic depends on scientists' ability to form cross-border partnerships, even as the US has weakened global ties
Brendan Borrell
Friday, May 1, 2020

Read the article from Wired about the global race to develop a vaccine for Covid-19.

 Brendan Borrell is a journalist based in Los Angeles and writes for The Atlantic, Audubon, National Geographic, Outside, and many other publications.

Also, read an article about herd immunity and Covid-19 from the Lancet, which reports more than 100 potential vaccines are under development. "Strategies in various countries that aim to stagger return to work on the basis of disease severity risk and age do not take account of how exposing even lower-risk individuals, such as young people with no comorbidities, to the virus so as to increase herd immunity can still result in pandemic spread. The only selective pressure on SARS-CoV-2 is transmission – stop transmission and you stop the virus. The linchpin for a strategy to move out of lockdown seemingly rests on increased testing and contact tracing, possible return-to-work permits based on immune status, repurposed or new therapeutics, and, finally, vaccination.... There is no certainty as to the immunological correlates of antiviral protection or the proportion of the population who must attain them, making it impossible to identify a point when this level of immunity has been reached."

Herd Imunity: Selected Vaccine Preventable Diseases 	 	 Measles	95% Pertussis	94% Rubella	86% Smallpox	86% SARS	80% Ebola	60% Influenza	44% Covid-19	  ?
Protection: Herd immunity against a disease occurs when a high percentage of the population is either vaccinated or survived infection, and their bodies can defend against new infection; vaccines for Covid-19 are still under develpment and there are many unknowns (Source: Our World in Data)

© 2020 Condé Nast. All rights reserved.